THE EFFECTIVENESS OF THE USE OF DIRECT-ACTING ANTICOAGULANTS IN THE TREATMENT OF PSORIASIS

Article Sidebar

PDF (Russian)
Published: 2026-02-05
DOI: https://doi.org/10.66073/researchfocus.v5i1.2001
Keywords:
psoriasis, microcirculation, PASI index, Angioflux, treatment effectiveness

Main Article Content

Toshev Suxrob Oktamjon ugli
Samarkand State Medical University, Samarkand, Uzbekistan

Abstract

The aim of the study was to assess the effectiveness of the drug Angioflux in correcting microcirculatory disorders in patients with psoriasis on the basis of the dynamics of the PASI index. A total of 142 patients with various clinical forms of psoriasis were examined and divided into an observation group and a comparison group. It was established that the inclusion of Angioflux in combined therapy contributes to a more pronounced and statistically significant decrease in the PASI index compared with standard treatment.

Article Details

Issue

Vol. 5 No. 1 (2026): Research Focus International Scientific Journal. Volume 5, Issue 1 (2026)

Section

14.00.00 – Medical sciences
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

THE EFFECTIVENESS OF THE USE OF DIRECT-ACTING ANTICOAGULANTS IN THE TREATMENT OF PSORIASIS. (2026). Research Focus International Scientific Journal, 5(1), 298-302. https://doi.org/10.66073/researchfocus.v5i1.2001

References

Raharja A., Mahil S. K., Barker J. N. Psoriasis: a brief overview //Clinical Medicine. – 2021. – Т. 21. – №. 3. – С. 170-173.

Smith C. H., Barker J. Psoriasis and its management //Bmj. – 2006. – Т. 333. – №. 7564. – С. 380-384.

Lowes M. A., Suarez-Farinas M., Krueger J. G. Immunology of psoriasis //Annual review of immunology. – 2014. – Т. 32. – №. 1. – С. 227-255.

Rendon A., Schäkel K. Psoriasis pathogenesis and treatment //International journal of molecular sciences. – 2019. – Т. 20. – №. 6. – С. 1475.

Kim W. B., Jerome D., Yeung J. Diagnosis and management of psoriasis //Canadian Family Physician. – 2017. – Т. 63. – №. 4. – С. 278-285.

Kamiya K. et al. Risk factors for the development of psoriasis //International journal of molecular sciences. – 2019. – Т. 20. – №. 18. – С. 4347.

Armstrong A. W., Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review //Jama. – 2020. – Т. 323. – №. 19. – С. 1945-1960.

Kuchekar A. B. et al. Psoriasis: A comprehensive review //Int J Pharm Life Sci. – 2011. – Т. 2. – №. 6. – С. 857-77.

Yamanaka K., Yamamoto O., Honda T. Pathophysiology of psoriasis: A review //The Journal of dermatology. – 2021. – Т. 48. – №. 6. – С. 722-731.

Rajguru J. P. et al. Update on psoriasis: A review //Journal of family medicine and primary care. – 2020. – Т. 9. – №. 1. – С. 20-24.

Kimmel G. W., Lebwohl M. Psoriasis: overview and diagnosis //Evidence-Based Psoriasis: Diagnosis and Treatment. – 2018. – С. 1-16.

Yamazaki F. Psoriasis: comorbidities //The Journal of dermatology. – 2021. – Т. 48. – №. 6. – С. 732-740.

Yamazaki F. Psoriasis: comorbidities //The Journal of dermatology. – 2021. – Т. 48. – №. 6. – С. 732-740.